Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Dolutegravir for the treatment of HIV.

Katlama C, Murphy R.

Expert Opin Investig Drugs. 2012 Apr;21(4):523-30. doi: 10.1517/13543784.2012.661713. Review.

PMID:
22380682
2.

Dolutegravir: an exciting new kid on the block.

Blanco Arévalo JL, Whitlock GG.

Expert Opin Pharmacother. 2014 Mar;15(4):573-82. doi: 10.1517/14656566.2014.868883. Review.

PMID:
24446762
3.

Dolutegravir: a new integrase strand transfer inhibitor for the treatment of HIV.

Shah BM, Schafer JJ, Desimone JA Jr.

Pharmacotherapy. 2014 May;34(5):506-20. doi: 10.1002/phar.1386. Review. Erratum in: Pharmacotherapy. 2014 Jun;34(6):667.

PMID:
24347095
4.

Dolutegravir: first global approval.

Ballantyne AD, Perry CM.

Drugs. 2013 Sep;73(14):1627-37. doi: 10.1007/s40265-013-0121-4. Review.

PMID:
24052331
5.

Dolutegravir, a second-generation integrase inhibitor for the treatment of HIV-1 infection.

Rathbun RC, Lockhart SM, Miller MM, Liedtke MD.

Ann Pharmacother. 2014 Mar;48(3):395-403. doi: 10.1177/1060028013513558. Review.

PMID:
24259658
6.

Dolutegravir for the treatment of adult patients with HIV-1 infection.

Wu G, Abraham T, Saad N.

Expert Rev Anti Infect Ther. 2014 May;12(5):535-44. doi: 10.1586/14787210.2014.907525. Review.

PMID:
24694091
7.

Emerging patterns and implications of HIV-1 integrase inhibitor resistance.

Geretti AM, Armenia D, Ceccherini-Silberstein F.

Curr Opin Infect Dis. 2012 Dec;25(6):677-86. doi: 10.1097/QCO.0b013e32835a1de7. Review.

PMID:
23086187
8.

[Efficacy of dolutegravir in treatment-experienced patients: the SAILING and VIKING trials].

Moreno S, Berenguer J.

Enferm Infecc Microbiol Clin. 2015 Mar;33 Suppl 1:26-30. doi: 10.1016/S0213-005X(15)30006-9. Review. Spanish.

PMID:
25858609
9.

Is resistance to dolutegravir possible when this drug is used in first-line therapy?

Mesplède T, Wainberg MA.

Viruses. 2014 Aug 27;6(9):3377-85. doi: 10.3390/v6093377. Review.

10.

HIV integrase inhibitors: a new era in the treatment of HIV.

Blanco JL, Whitlock G, Milinkovic A, Moyle G.

Expert Opin Pharmacother. 2015 Jun;16(9):1313-24. doi: 10.1517/14656566.2015.1044436. Review.

PMID:
26001181
11.

Might dolutegravir be part of a functional cure for HIV?

Wainberg MA, Han YS, Mesplède T.

Can J Microbiol. 2016 May;62(5):375-82. doi: 10.1139/cjm-2015-0725. Review.

12.

Integrase strand transfer inhibitors in the management of HIV-positive individuals.

Mesplède T, Quashie PK, Zanichelli V, Wainberg MA.

Ann Med. 2014 May;46(3):123-9. doi: 10.3109/07853890.2014.883169. Review.

PMID:
24579911
13.

Novel integrase inhibitors for HIV.

Prada N, Markowitz M.

Expert Opin Investig Drugs. 2010 Sep;19(9):1087-98. doi: 10.1517/13543784.2010.501078. Review.

PMID:
20707594
14.

S/GSK1349572, a new integrase inhibitor for the treatment of HIV: promises and challenges.

Lenz JC, Rockstroh JK.

Expert Opin Investig Drugs. 2011 Apr;20(4):537-48. doi: 10.1517/13543784.2011.562189. Review.

PMID:
21381981
15.

Drug safety profile of integrase strand transfer inhibitors.

Gutierrez Mdel M, Mateo MG, Vidal F, Domingo P.

Expert Opin Drug Saf. 2014 Apr;13(4):431-45. doi: 10.1517/14740338.2014.897327. Review.

PMID:
24597519
16.

Dolutegravir: a next-generation integrase inhibitor for treatment of HIV infection.

Osterholzer DA, Goldman M.

Clin Infect Dis. 2014 Jul 15;59(2):265-71. doi: 10.1093/cid/ciu221. Review.

PMID:
24723281
17.

The use of HIV-1 integrase inhibitors in antiretroviral naive patients.

Lennox JL.

Curr Opin HIV AIDS. 2012 Sep;7(5):409-14. doi: 10.1097/COH.0b013e3283562a27. Review.

PMID:
22789985
18.

[Integrase inhibitors - new challenges for the treatment of HIV-1 infections].

Stock I.

Med Monatsschr Pharm. 2013 Dec;36(12):448-59; quiz 461-2. Review. German.

PMID:
24450269
19.

HIV type 1 integrase inhibitors: from basic research to clinical implications.

Jegede O, Babu J, Di Santo R, McColl DJ, Weber J, Quiñones-Mateu M.

AIDS Rev. 2008 Jul-Sep;10(3):172-89. Review.

PMID:
18820719
20.

New first and second generation inhibitors of human immunodeficiency virus-1 integrase.

Pendri A, Meanwell NA, Peese KM, Walker MA.

Expert Opin Ther Pat. 2011 Aug;21(8):1173-89. doi: 10.1517/13543776.2011.586631. Review.

PMID:
21599420

Supplemental Content

Support Center